Corleen Roche
Financieel Directeur/CFO bij CG ONCOLOGY, INC.
Vermogen: 72 400 $ op 30-04-2024
Profiel
Corleen M.
Roche is currently the Chief Financial Officer, CAO & Secretary at CG Oncology, Inc. She previously held positions as the Chief Financial Officer-US at Biogen, Inc., the Chief Financial Officer at Sandoz, Inc., the Chief Financial & Accounting Officer at Immunome, Inc., the Chief Financial Officer at Iogenetics LLC, and the Chief Financial Officer at Wyeth Pharmaceuticals, Inc. Ms. Roche obtained her undergraduate degree from Villanova University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
CG ONCOLOGY, INC.
0.00% | 29-01-2024 | 2 000 ( 0.00% ) | 72 400 $ | 30-04-2024 |
IMMUNOME, INC.
-.--% | 08-06-2023 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Corleen Roche
Bedrijven | Functie | Begin |
---|---|---|
CG ONCOLOGY, INC. | Financieel Directeur/CFO | 01-01-2024 |
Eerdere bekende functies van Corleen Roche
Bedrijven | Functie | Einde |
---|---|---|
IMMUNOME, INC. | Financieel Directeur/CFO | 02-01-2024 |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Financieel Directeur/CFO | - |
Iogenetics LLC | Financieel Directeur/CFO | - |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Financieel Directeur/CFO | - |
BIOGEN INC. | Financieel Directeur/CFO | - |
Opleiding van Corleen Roche
Villanova University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
BIOGEN INC. | Health Technology |
IMMUNOME, INC. | Health Technology |
CG ONCOLOGY, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
Iogenetics LLC | |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |